Affinibody
The 2024 Journal Citation Reports (JCR) were updated on June 20, 2024, covering a comprehensive range of quality journals ranked by subject category.
CA: A Cancer Journal for Clinicians retained its leading position. Impact factors of NEJM, The Lancet, JAMA and BMJ generally declined, while journals such as Signal Transduction and Targeted Therapy gained prominence.
We have compiled the full list, including JIF and five-year JIF values. These metrics can help assess journal influence and inform submission planning.
(Sample shown; the full list includes over 20,000 journals.)
1. Send “JCR2024” to our official WeChat account.
2. Scan the QR code below.
Research is increasingly competitive, but sustained effort matters. We wish every researcher successful publications and rewarding scientific discoveries.
Based in Wuhan, Affinibody Life Science Co., Ltd. develops and supplieskey enzymes,、key antibodiesandBiochemical Reagentsthrough research, manufacturing and application services. Our AI-assisted protein design and NMR-guided directed evolution platforms support research and diagnostic enzymes, enzymes for genetically modified plants, and nanobodies for cell therapy, multispecific antibodies and antibody-mediated protein degradation.
Serving green manufacturing, human health and scientific research, Affinibody combines craftsmanship with a commitment to world-class products. We offer better choices for research, industry and everyday life, supporting sustainable development.
